# Vita Coco Company, Inc.: financial statements, quarterly

COCO · Nasdaq · CIK 1482981 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/coco.md) · [Financials](/companies/coco/financials.md) · [Filings](/companies/coco/filings.md) · [Insiders](/companies/coco/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/coco/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [106 d](/filings/0001482981-26-000022.md) | [112](/filings/0001482981-25-000082.md) | [144](/filings/0001482981-25-000133.md) | [133](/filings/0001628280-25-046935.md) | [127 d](/filings/0001482981-26-000022.md) | [131](/filings/0001482981-26-000120.md) | [169](/filings/0001482981-26-000173.md) | [182](/filings/0001482981-26-000185.md) | [128 d](/filings/0001482981-26-000022.md) | [180](/filings/0001482981-26-000120.md) | [216](/filings/0001482981-26-000173.md) | [244](/filings/0001482981-26-000185.md) |
| Cost of revenue | $m | [66.3 d](/filings/0001482981-26-000022.md) | [64.5](/filings/0001482981-25-000082.md) | [85.4](/filings/0001482981-25-000133.md) | [81.3](/filings/0001628280-25-046935.md) | [86.0 d](/filings/0001482981-26-000022.md) | [82.8](/filings/0001482981-26-000120.md) | [107](/filings/0001482981-26-000173.md) | [114](/filings/0001482981-26-000185.md) | [83.2 d](/filings/0001482981-26-000022.md) | [108](/filings/0001482981-26-000120.md) | [111](/filings/0001482981-26-000173.md) | [151](/filings/0001482981-26-000185.md) |
| Gross profit | $m | [39.8 d](/filings/0001482981-26-000022.md) | [47.2](/filings/0001482981-25-000082.md) | [58.7](/filings/0001482981-25-000133.md) | [51.6](/filings/0001628280-25-046935.md) | [41.3 d](/filings/0001482981-26-000022.md) | [48.1](/filings/0001482981-26-000120.md) | [61.3](/filings/0001482981-26-000173.md) | [68.7](/filings/0001482981-26-000185.md) | [44.6 d](/filings/0001482981-26-000022.md) | [71.8](/filings/0001482981-26-000120.md) | [105](/filings/0001482981-26-000173.md) | [92.7](/filings/0001482981-26-000185.md) |
| Selling, general and administrative | $m | [34.4 d](/filings/0001482981-26-000022.md) | [28.2](/filings/0001482981-25-000082.md) | [28.8](/filings/0001482981-25-000133.md) | [31.0](/filings/0001628280-25-046935.md) | [37.0 d](/filings/0001482981-26-000022.md) | [28.8](/filings/0001482981-26-000120.md) | [36.1](/filings/0001482981-26-000173.md) | [40.7](/filings/0001482981-26-000185.md) | [34.4 d](/filings/0001482981-26-000022.md) | [38.2](/filings/0001482981-26-000120.md) | [42.2](/filings/0001482981-26-000173.md) | [47.2](/filings/0001482981-26-000185.md) |
| Operating income | $m | [5.4 d](/filings/0001482981-26-000022.md) | [19.0](/filings/0001482981-25-000082.md) | [30.0](/filings/0001482981-25-000133.md) | [20.6](/filings/0001628280-25-046935.md) | [4.3 d](/filings/0001482981-26-000022.md) | [19.3](/filings/0001482981-26-000120.md) | [25.1](/filings/0001482981-26-000173.md) | [27.9](/filings/0001482981-26-000185.md) | [10.2 d](/filings/0001482981-26-000022.md) | [33.6](/filings/0001482981-26-000120.md) | [63.1](/filings/0001482981-26-000173.md) | [45.5](/filings/0001482981-26-000185.md) |
| Interest expense | $m | [0.0 d](/filings/0001482981-24-000012.md) | [0.0](/filings/0001482981-24-000064.md) | [0.0](/filings/0001482981-24-000102.md) | [0.0](/filings/0001482981-24-000127.md) | [0.0 d](/filings/0001482981-25-000032.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.2 d](/filings/0001482981-26-000022.md) | [3.8](/filings/0001482981-25-000082.md) | [6.4](/filings/0001482981-25-000133.md) | [6.4](/filings/0001628280-25-046935.md) | [(1.7) d](/filings/0001482981-26-000022.md) | [5.5](/filings/0001482981-26-000120.md) | [5.3](/filings/0001482981-26-000173.md) | [6.7](/filings/0001482981-26-000185.md) | [4.2 d](/filings/0001482981-26-000022.md) | [7.0](/filings/0001482981-26-000120.md) | [14.9](/filings/0001482981-26-000173.md) | [8.6](/filings/0001482981-26-000185.md) |
| Net income | $m | [6.8 d](/filings/0001482981-26-000022.md) | [14.2](/filings/0001482981-25-000082.md) | [19.1](/filings/0001482981-25-000133.md) | [19.3](/filings/0001628280-25-046935.md) | [3.4 d](/filings/0001482981-26-000022.md) | [18.9](/filings/0001482981-26-000120.md) | [22.9](/filings/0001482981-26-000173.md) | [24.0](/filings/0001482981-26-000185.md) | [5.5 d](/filings/0001482981-26-000022.md) | [30.5](/filings/0001482981-26-000120.md) | [49.5](/filings/0001482981-26-000173.md) | [35.0](/filings/0001482981-26-000185.md) |
| Diluted EPS | $ per share | not reported | [0.24](/filings/0001482981-25-000082.md) | [0.32](/filings/0001482981-25-000133.md) | [0.32](/filings/0001628280-25-046935.md) | not reported | [0.31](/filings/0001482981-26-000120.md) | [0.38](/filings/0001482981-26-000173.md) | [0.40](/filings/0001482981-26-000185.md) | not reported | [0.50](/filings/0001482981-26-000120.md) | [0.82](/filings/0001482981-26-000173.md) | [0.58](/filings/0001482981-26-000185.md) |
| Basic EPS | $ per share | not reported | [0.25](/filings/0001482981-25-000082.md) | [0.34](/filings/0001482981-25-000133.md) | [0.34](/filings/0001628280-25-046935.md) | not reported | [0.33](/filings/0001482981-26-000120.md) | [0.40](/filings/0001482981-26-000173.md) | [0.42](/filings/0001482981-26-000185.md) | not reported | [0.53](/filings/0001482981-26-000120.md) | [0.86](/filings/0001482981-26-000173.md) | [0.61](/filings/0001482981-26-000185.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [133](/filings/0001482981-25-000032.md) | [123](/filings/0001482981-24-000064.md) | [150](/filings/0001482981-24-000102.md) | [157](/filings/0001482981-24-000127.md) | [165](/filings/0001482981-26-000022.md) | [154](/filings/0001482981-25-000082.md) | [167](/filings/0001482981-25-000133.md) | [204](/filings/0001628280-25-046935.md) | [197](/filings/0001482981-26-000185.md) | [202](/filings/0001482981-26-000120.md) | [279](/filings/0001482981-26-000173.md) | [152](/filings/0001482981-26-000185.md) |
| Current assets | $m | [263](/filings/0001482981-25-000032.md) | [267](/filings/0001482981-24-000064.md) | [301](/filings/0001482981-24-000102.md) | [331](/filings/0001482981-24-000127.md) | [341](/filings/0001482981-26-000022.md) | [351](/filings/0001482981-25-000082.md) | [387](/filings/0001482981-25-000133.md) | [423](/filings/0001628280-25-046935.md) | [421](/filings/0001482981-26-000185.md) | [450](/filings/0001482981-26-000120.md) | [535](/filings/0001482981-26-000173.md) | [434](/filings/0001482981-26-000185.md) |
| Total assets | $m | [286](/filings/0001482981-26-000022.md) | [289](/filings/0001482981-24-000064.md) | [323](/filings/0001482981-24-000102.md) | [353](/filings/0001482981-24-000127.md) | [362](/filings/0001482981-26-000022.md) | [384](/filings/0001482981-25-000082.md) | [421](/filings/0001482981-25-000133.md) | [461](/filings/0001628280-25-046935.md) | [461](/filings/0001482981-26-000185.md) | [488](/filings/0001482981-26-000120.md) | [573](/filings/0001482981-26-000173.md) | [696](/filings/0001482981-26-000185.md) |
| Current liabilities | $m | [82.6](/filings/0001482981-25-000032.md) | [79.0](/filings/0001482981-24-000064.md) | [90.8](/filings/0001482981-24-000102.md) | [101](/filings/0001482981-24-000127.md) | [103](/filings/0001482981-26-000022.md) | [93.4](/filings/0001482981-25-000082.md) | [110](/filings/0001482981-25-000133.md) | [123](/filings/0001628280-25-046935.md) | [116](/filings/0001482981-26-000185.md) | [123](/filings/0001482981-26-000120.md) | [159](/filings/0001482981-26-000173.md) | [175](/filings/0001482981-26-000185.md) |
| Total liabilities | $m | [83.2](/filings/0001482981-25-000032.md) | [79.4](/filings/0001482981-24-000064.md) | [91.0](/filings/0001482981-24-000102.md) | [101](/filings/0001482981-24-000127.md) | [104](/filings/0001482981-26-000022.md) | [106](/filings/0001482981-25-000082.md) | [124](/filings/0001482981-25-000133.md) | [138](/filings/0001628280-25-046935.md) | [130](/filings/0001482981-26-000185.md) | [136](/filings/0001482981-26-000120.md) | [172](/filings/0001482981-26-000173.md) | [267](/filings/0001482981-26-000185.md) |
| Shareholders' equity | $m | [202](/filings/0001482981-25-000032.md) | [210](/filings/0001482981-24-000064.md) | [232](/filings/0001482981-24-000102.md) | [252](/filings/0001482981-24-000127.md) | [259](/filings/0001482981-26-000022.md) | [278](/filings/0001482981-25-000082.md) | [297](/filings/0001482981-25-000133.md) | [324](/filings/0001628280-25-046935.md) | [332](/filings/0001482981-26-000185.md) | [352](/filings/0001482981-26-000120.md) | [401](/filings/0001482981-26-000173.md) | [429](/filings/0001482981-26-000185.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [37.2 d](/filings/0001482981-26-000022.md) | [(0.3)](/filings/0001482981-25-000082.md) | [26.9 d](/filings/0001482981-25-000133.md) | [9.3 d](/filings/0001628280-25-046935.md) | [6.9 d](/filings/0001482981-26-000022.md) | [(9.8)](/filings/0001482981-26-000120.md) | [21.8 d](/filings/0001482981-26-000173.md) | [39.1 d](/filings/0001482981-26-000185.md) | [(3.9) d](/filings/0001482981-26-000022.md) | [15.6](/filings/0001482981-26-000120.md) | [80.9 d](/filings/0001482981-26-000173.md) | [55.4 d](/filings/0001482981-26-000185.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001482981-26-000022.md) | [0.1](/filings/0001482981-25-000082.md) | [0.3 d](/filings/0001482981-25-000133.md) | [0.4 d](/filings/0001628280-25-046935.md) | [0.1 d](/filings/0001482981-26-000022.md) | [0.6](/filings/0001482981-26-000120.md) | [0.9 d](/filings/0001482981-26-000173.md) | [3.4 d](/filings/0001482981-26-000185.md) | [3.2 d](/filings/0001482981-26-000022.md) | [0.5](/filings/0001482981-26-000120.md) | [0.2 d](/filings/0001482981-26-000173.md) | [0.2 d](/filings/0001482981-26-000185.md) |
| Share repurchases | $m | [0.8 d](/filings/0001482981-26-000022.md) | [9.2](/filings/0001482981-25-000082.md) | [0.0 d](/filings/0001482981-25-000133.md) | [2.8 d](/filings/0001628280-25-046935.md) | [0.0 d](/filings/0001482981-26-000022.md) | [1.5](/filings/0001482981-26-000120.md) | [8.6](/filings/0001482981-25-000133.md) | [0.2](/filings/0001628280-25-046935.md) | [1.1 d](/filings/0001482981-26-000173.md) | [11.5](/filings/0001482981-26-000120.md) | [8.5](/filings/0001482981-26-000173.md) | [42.4 d](/filings/0001482981-26-000185.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.4](/filings/0001482981-24-000064.md) | [58.9](/filings/0001482981-24-000102.md) | [59.3](/filings/0001482981-24-000127.md) | [58.7](/filings/0001482981-25-000082.md) | [59.2](/filings/0001482981-25-000133.md) | [59.3](/filings/0001628280-25-046935.md) | [60.0](/filings/0001482981-26-000120.md) | [59.6](/filings/0001482981-26-000173.md) | [59.9](/filings/0001482981-26-000185.md) | [60.5](/filings/0001482981-26-000120.md) | [60.6](/filings/0001482981-26-000173.md) | [60.8](/filings/0001482981-26-000185.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 57,063,861 at 2026-10-20, from the cover of the [10-Q filed 2026-10-22](/filings/0001482981-26-000185.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.